NEWS

NEWS

Press Releases NEWS PAGE COMPANY INDEX Press Releases

 

Idun Pharmaceuticals, Inc.
Idun Pharmaceuticals creates innovative human therapeutics with a primary focus on controlling apoptosis, or programmed cell death. Idun's focus is on small molecule therapeutics that act to either inhibit or stimulate apoptosis. In its drug discovery programs, Idun is targeting proteins that have been shown genetically and functionally to be key control points in the apoptosis pathway.
Idun has a broad patent portfolio, including 36 issued patents, covering many of the key genes involved in the regulation of apoptosis.
July 99

Idun Pharmaceuticals initiates plant apoptosis protection program (2029)

.

11085 North Torrey Pines Road, Suite 300 · La Jolla, California 92037 · Tel: +1 619-623-1330

Copyright © 1998 SeedQuest - All rights reserved